We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£495.00
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 3 months
2023-2028 Anti-Viral Nucleotide Polymerase Inhibitor Drugs Outlook China
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 37 days · 37 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 37 days • 1 price levels
Price Analysis
Most common price: £495 (37 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 37 days
Description
Key Features
Covers latent demand forecasts for anti-viral nucleotide polymerase inhibitor drugs across all Chinese regions including provinces, autonomous regions, municipalities, and special administrative regions.
Provides potential industry earnings estimates for approximately 1,100 cities throughout China, enabling location-specific market analysis and targeting.
Delivers five-year outlook data from 2023 to 2028, supporting long-term strategic planning and investment decisions in the Chinese pharmaceutical market.
Published by ICON Group International, a recognised provider of market research and industry analysis for global pharmaceutical sectors.
Product Specifications
- Format
- paperback
- ASIN
- B0BBJZQ7S8
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 16 August 2022
- Listed Since
- 25 August 2022
Similar Products You Might Like
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs for US Zip Codes
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in the United States
2023-2028 Nasal Drug Delivery Outlook for China - Market Research
2023-2028 Injectable Drug Delivery Devices Outlook China
2023-2028 Viral Clearance Services Outlook China
2023-2028 Orphan Diseases Therapeutics CNS China Outlook
2023-2028 Acute Agitation Aggression Treatments Outlook China
2023-2028 China Vitamins Supplements Medicines Outlook
The 2023-2028 Outlook for Hepatitis Drugs in the United States
Aneurysmal Subarachnoid Hemorrhage Drugs Outlook China 2023-2028
Emergency Contraceptive Pills China Market Outlook 2023-2028
2023-2028 Hypercalcemia Treatment Outlook for China
The 2023-2028 Outlook for Pet Veterinary Drugs in China
2023-2028 Mycotoxin Binders Outlook for China - Market Analysis
China Contraceptive Implantable Drug Delivery Devices 2023-2028 Outlook
2023-2028 Uterine Sarcoma Therapeutics & Diagnostics Outlook - China
The 2023-2028 Outlook for Hepatitis Therapeutics in the United States
The 2019-2024 Outlook for Antibody Drugs in China
The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes
2023-2028 Orphan Diseases Oncology Therapeutics Outlook China
The 2023-2028 Outlook for Antifungal Drugs in India
The 2023-2028 Outlook for Liver Cirrhosis Drugs in the United States